|
Fulvicin-u/fDrug - Fulvicin-u/f The trade name of the product as shown on the labeling.
Dosage -
TABLET; ORAL
Active Ingredient(s) -
Griseofulvin, Microcrystalline
Strength -
250MG
Applicant -
SCHERING
New Drug Application (NDA) Number -
060569
Product Number -
002
Therapeutic Equivalence (TE) Code -
AB
Approval Date -
Approved Prior to Jan 1, 1982
Reference Listed Drug (RLD) -
Yes
Type -
RX
Applicant Full Name -
Schering Corp Sub Schering Plough Corp
Fulvicin-u/f
Raxar Eq 200mg Base Tablet; Oral
Raxar Eq 400mg Base Tablet; Oral Raxar Eq 600mg Base Tablet; Oral Grisactin 125mg Capsule; Oral Grisactin 250mg Capsule; Oral Grifulvin V 125mg/5ml Suspension; Oral Grifulvin V 125mg/5ml Suspension; Oral Griseofulvin 125mg/5ml Suspension; Oral Fulvicin-u/f 250mg Tablet; Oral Kytril Eq 2mg Base Tablet; Oral NewDrugInformation |